IVF medication costs have risen 84% in a decade while the top fertility drug is 700% more expensive in the US than abroad

The average cost of IVF medications in the United States increased from $696.85 in 2014 to $1,279.20 in 2024, an 84% increase that far exceeds the 37% average price increase across all prescription drugs in the same period. The number one fertility drug used in IVF is currently 700% more expensive in the United States than the rest of the world, and medications account for nearly 20% of total IVF cycle costs ($1,500 to $7,000+ per cycle). Why it matters: fertility drugs are disproportionately expensive, so patients already paying $15,000-$30,000 per IVF cycle face an additional $3,000-$7,000 medication bill that insurance rarely covers, so an estimated 85% of IVF costs are paid out of pocket, so many patients cannot afford the 2-3 cycles typically needed (the average patient undergoes 2.3-2.7 cycles), so the total financial burden reaches approximately $50,000 per patient, so lower-income individuals are systematically excluded from assisted reproduction. The structural root cause is that most IVF medications are biologics protected by patents with no generic alternatives, the fertility drug market is dominated by a small number of manufacturers (primarily EMD Serono, Ferring, and Merck), and the US lacks the pharmaceutical price negotiation mechanisms that other countries use to keep these same drugs affordable.